6505--Tadalafil Tablets (VA-24-00107372)
ID: 36E79724R0033Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/b30d483be0a542e3b0faa8396b81a6dd/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is soliciting proposals for the acquisition of Tadalafil tablets under the solicitation titled "6505--Tadalafil Tablets (VA-24-00107372)." Bidders are required to provide pricing for four different dosages of Tadalafil for a base year and four option years, ensuring compliance with a 0.5% Cost Recovery Fee and the provision of unique National Drug Code (NDC) numbers for each product. This procurement is critical for maintaining a reliable pharmaceutical supply chain to support VA facilities, the Indian Health Service, and state veteran homes, thereby ensuring consistent product availability and adherence to safety and packaging standards. Interested parties should contact Contract Specialist Billy Fong at Billy.Fong@va.gov for further details regarding the submission process and requirements.

    Point(s) of Contact
    Billy FongContract Specialist
    Billy.Fong@va.gov
    Files
    Title
    Posted
    36E79724R0033_1.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0033 regarding the procurement of Tadalafil Tablets. This unrestricted contract is intended for various federal entities, including the Department of Defense and the Bureau of Prisons. The selected contractor is expected to ensure a continuous supply of Tadalafil, with a contract period of one year and four optional annual extensions. Offerors must provide specific labeling information and adhere to packaging requirements, including safety features and dimensions for the bottles. The RFP will be launched on or about October 29, 2024, with proposals due by November 12, 2024. The estimated annual requirements include significant quantities of various Tadalafil strengths, totaling approximately 322,854 bottles. Interested parties can access documents and updates at sam.gov, and inquiries should be directed to Contract Specialist Billy Fong via email. This procurement aims to address the medication needs of veterans and other federal healthcare programs, ensuring compliance and quality service provision.
    36E79724R0033.docx
    This document outlines a government Request for Proposals (RFP) by the Department of Veterans Affairs (VA) for the acquisition of Tadalafil tablets through the VA and Department of Defense (DoD) Pharmaceutical Prime Vendor Programs. The RFP specifies the need for bidders to submit pricing for four different dosages of Tadalafil for a base year and four option years, including compliance with a 0.5% Cost Recovery Fee. It stresses the importance of unique National Drug Code (NDC) numbers for each product offered and mandates adherence to safety and packaging requirements. The contractor must maintain business agreements with Prime Vendors for product fulfillment and ensure compliance with the Drug Supply Chain Security Act (DSCSA). Additionally, the document establishes guidelines for backorders, recalls, product registration, and the submission of quarterly sales reports with accurate sales data. Following award, the contract will cover specific government participants including VA facilities, the Indian Health Service, and state veteran homes, focusing on consistent product availability and volume-based pricing. The solicitation emphasizes a robust and compliant pharmaceutical supply chain to ensure the VA can meet its health care obligations effectively.
    Lifecycle
    Title
    Type
    6505--Tadalafil Tablets (VA-24-00107372)
    Currently viewing
    Solicitation
    6505--Tadalafil Tablets (VA-24-00107372)
    Presolicitation
    Similar Opportunities
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to ensure an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will have a duration of one year, with the potential for four additional one-year options, and the estimated annual requirements include specific dosages and quantities of the tablets. Interested vendors must submit their proposals by December 4, 2024, and are encouraged to check SAM.gov for updates regarding the solicitation. For inquiries, vendors can contact Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or by phone at 708-786-5894.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0005 to procure Abiraterone Acetate Tablets, an essential medication for various federal health care programs. The procurement aims to secure a reliable supply of 250mg Abiraterone Acetate Tablets, with an estimated annual requirement of 71,997 bottles, to support the VA, Department of Defense, Bureau of Prisons, and other federal entities. This contract will span one base year with four optional one-year extensions, ensuring continuity of supply for critical health services. Interested offerors should monitor sam.gov for the electronic issuance of the solicitation on or about November 22, 2024, with a closing date of December 6, 2024; inquiries can be directed to Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0007 for the procurement of Warfarin Tablets, aimed at ensuring a reliable supply for various federal health agencies, including the Department of Defense and the Bureau of Prisons. This unrestricted procurement will cover multiple tablet strengths and packaging sizes, with an estimated annual usage detailed across 16 product types, and will be awarded for an initial one-year period with options for four additional years. The successful contractor must provide unique labeling and a National Drug Code (NDC) associated with their product, emphasizing the importance of compliance with federal regulations in pharmaceutical supply. Interested vendors should note that the solicitation will be electronically issued around November 13, 2024, with a response deadline of November 27, 2024; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.
    6505--Metformin SA Tablets REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL SA Tablets, aimed at ensuring a consistent supply for various governmental entities, including the VA, Department of Defense, Bureau of Prisons, and others. The procurement will cover a one-year contract with the possibility of four additional one-year extensions, requiring offerors to provide a unique National Drug Code (NDC) number and distinct labeling for the supplied products. This initiative is critical for maintaining the availability of essential pharmaceuticals, with estimated annual requirements detailed for two groups: Other Government Agencies and the VA Repack Program. The solicitation, numbered 36E79725R0003, is scheduled for electronic release on December 3, 2024, with a closing date of December 17, 2024. Interested parties can direct inquiries to Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852, and are encouraged to monitor SAM.gov for updates.
    6505--Aspirin_Dipyridamole SA Capsules (VA-25-00011491)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting offers for the procurement of Aspirin 25MG/Dipyridamole 200MG Sustained Action Capsules under solicitation number VA-25-00011491. This procurement aims to ensure a reliable supply chain for pharmaceuticals critical to various governmental health agencies, including the Department of Defense and Indian Health Services, and requires offerors to submit pricing for a base year and four option years, along with a Cost Recovery Fee of 0.5%. Compliance with the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards is mandatory, and contractors must adhere to stringent packaging and labeling guidelines while demonstrating past performance evaluations. Interested parties should contact Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details.
    6505--Mycophenolate Mofetil RFI
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting market research for the procurement of Mycophenolate Mofetil capsules and tablets, intended for use by multiple federal agencies, including the Department of Defense and the Indian Health Service. The objective is to establish a national mandatory requirements contract that will ensure lower pricing based on committed volume, with a preference for a long-term agreement consisting of a base year and up to four option years. This procurement is crucial for maintaining the availability of essential pharmaceuticals within federal healthcare systems. Interested companies must respond by November 19, 2024, providing specific information such as a unique National Drug Code, evidence of manufacturer relationships, and compliance with distribution agreements. For inquiries, contact Amber Zavala at amber.zavala@va.gov or call 708-786-5160.
    6505--Omeprazole Dr Capsules- NAC Repack
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Omeprazole Dr Capsules through its NAC Pharmaceuticals office. This opportunity requires contractors to submit pricing for both base and option years while adhering to stringent manufacturing and packaging regulations, including compliance with the Drug Supply Chain Security Act (DSCSA) and FDA Good Manufacturing Practice (cGMP) standards. The capsules will serve critical needs for both the VA and other government agencies under the Pharmaceutical Prime Vendor Program and the Pharmaceutical Repackaging Program. Interested contractors should contact Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov for further details, as the contract may extend up to five years with options for renewal.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the supply of Lamotrigine Immediate Release (IR) Tablets as part of its Pharmaceutical Prime Vendor (PPV) Program. The objective of this procurement is to establish a reliable supply source for these pharmaceuticals, ensuring their availability and implementing volume-based pricing for various government agencies, including the Department of Defense and Indian Health Services. Compliance with the Drug Supply Chain Security Act, stringent packaging requirements, and adherence to FDA cGMP standards are critical components of this contract, which includes a base year and four option years. Interested bidders should contact Contract Specialist Ray Roldan at Raymond.Roldan@va.gov for further details and to submit their proposals.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Pegfilgrastim, a critical pharmaceutical product, through its Pharmaceutical Prime Vendor (PPV) program. The objective of this solicitation is to establish a reliable supply chain for specified medications at competitive prices, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and promoting small business participation. Pegfilgrastim is essential for patients undergoing chemotherapy, as it helps to stimulate the production of white blood cells, thereby reducing the risk of infection. Interested offerors must submit proposals that include unique National Drug Codes (NDCs), pricing for a base year and four optional renewal years, and details on compliance with safety standards. For further inquiries, contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.